The Drug Control Department of Rajasthan, supported by local police, has seized a massive stockpile of 274 cartons of illicit medicines valued at approximately ₹5 crore from an abandoned dry well in Khatnawali village, located in the Bayana tehsil of Bharatpur district. The three-day recovery operation uncovered critical prescription drugs—including medications for heart conditions, diabetes, and pain relief—prompting a multi-state investigation expanding into neighboring Uttar Pradesh to dismantle an illegal pharmaceutical supply network.
Shocking Discovery in Khatnawali Village
The massive haul came to light following a tip-off received by the Assistant Drug Controller in Bharatpur. Acting on the intelligence, a specialized team from the Drug Control Department, accompanied by local law enforcement officers and village volunteers, descended upon a rural property in Khatnawali.
Initial visual inspections of the abandoned, dry well suggested a moderate stash of around 150 cartons. However, as recovery teams carefully hauled the concealed materials to the surface over a meticulous three-day operation, the final count swelled to 274 large cartons tightly packed with commercial pharmaceutical products.
The physical condition of the well had protected the cartons from immediate rain damage, but the unapproved and hazardous storage conditions raised immediate public safety alarms. The entire stock was formally impounded under legal protocol and transported to secure storage facilities for inventory auditing.
Critical Life-Saving Drugs Recovered
Preliminary classification of the seized stock revealed high-value brand-name medications used to treat chronic and critical conditions. Among the recovered pharmaceuticals were prominent medications including Losar-50 (prescribed for hypertension), Janumet and Jalra (used in diabetes management), Allegra-M (an anti-allergic formulation), and Ketorol-M (an anti-inflammatory painkiller).
Drug control inspectors drew 10 representative samples from the recovered consignment and dispatched them to state forensic laboratories for chemical analysis. The lab tests aim to determine whether the drugs are:
Genuine Commercial Stock: Authentic manufactured medicines diverted from legitimate distribution channels.
Counterfeit or Substandard: Spurious formulations manufactured in illicit units without active pharmaceutical ingredients.
Expired or Relabeled Products: Expired medical batches intended for unauthorized date-stamping and illegal resale in secondary markets.
Multi-State Links and Inter-State Operations
The sheer volume of pharmaceuticals recovered from a single rural dry well points to an organized, high-level syndicate capable of intercepting large-scale supply chains. Investigators quickly realized the network's reach extended well beyond Rajasthan's borders.
Following coordination with Uttar Pradesh drug enforcement authorities and manufacturing companies, raiding teams traced connected distribution links across state lines to Agra. A joint raid in Agra led to the seizure of additional related pharmaceutical stocks and the registration of a formal First Information Report (FIR) at Malpura Police Station against key suspects.
Officials are reviewing batch numbers, manufacturing dates, and dispatch registers provided by pharmaceutical manufacturers to trace the exact leak point in the supply chain—from clearing and forwarding (C&F) agents to wholesale distributors.
Strict Action Promised by Authorities
The recovery of ₹5 crore worth of medicines in an unregulated environment poses severe risks to consumer health if such stock enters the open market. Medical experts emphasize that improper temperature control in dry wells degrades active chemical compounds, turning vital life-saving drugs into ineffective or toxic substances.
Senior officials from the Rajasthan Drug Control Department assured that strict legal action under the Drugs and Cosmetics Act will be pressed against all individuals, C&F agencies, or distributors found complicit. As forensic results from the collected samples are awaited, state authorities have alerted regional medical associations and pharmacy networks to report any suspicious or unverified wholesale medicine offers.